aetherAI Hema
Commercial- Indications
- Blood disorders
Company intelligence / Profile preview
aetherAI has developed commercialized digital pathology platforms such as aetherSlide and AI-powered solutions like aetherAI Hema. Their systems are implemented across major medical centers in Taiwan, with growing international collaborations. Clinical results include improved polyp detection rates during colonoscopy, enhanced cancer review quality, and streamlined cross-hospital communication for pathologists. The company’s solutions have received multiple awards for innovation and excellence.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on aetherAI.